Ciesielski D, Dziewulska-Bokiniec A, Zółtowska A, Roszkiewicz A, Kopacz A, Wojtacki J
Department of Immunopathology, Medical University of Gdańsk, Poland.
Neoplasma. 1995;42(5):235-7.
In this article the results of molecular marker p53 examinations were presented in relation to the following established breast cancer prognostic factors: age, histologic type, histologic grade, lymph node involvement, tumor size as well as estrogen a progesterone receptor status. Twenty one percent of these primary breast cancer specimens exhibited the overexpression of p53 protein. Significant associations were found between p53 overexpression and younger age, high histologic grade and low content of estrogen and progesterone receptors. Identification of p53-positive breast carcinomas potentially represents a clinically useful indicator of breast cancer aggressiveness.